ML Gold Corp (TSX-V:$MLG) has received a permit to conduct a phase 2 drill program at the Palmetto gold project in Nevada. The company previously completed the first phase of drilling in June and followed with the maiden resource of approximately 350,000 gold equivalent ounces. The phase 2 program is designed to grow the current resource and to test parallel structures within the developing Palmetto gold trend.
Aurinia Pharmaceuticals Inc (TSX:$AUP) plans to expand its voclosporin renal franchise to include focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). The company also intends to evaluate its proprietary voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES) and begin a phase IIa tolerability study.
Northern Shield Resources Inc (TSX-V:$NRN) has received assay results from its 2017 drill program at the Huckleberry property, during which 982 core samples were processed from eight drill holes. Highlights include 20.5 meters of 0.18% copper, 0.08% nickel and 0.20% platinum group elements plus gold.
Rogue Resources Inc (TSX-V:$RRS) has entered an agreement to buy the Snow White quartz project located near Massey, Ontario, from a Sudbury-based prospector. The project consists of two staked mining claims representing approximately 96 hectares. It currently has Class A and Class B pit quarry aggregate permits for unlimited annual silica/quartz production.
Macarthur Minerals Ltd (TSX-V:$MMS) has confirmed the potential for high-grade gold on its Pilbara tenements following a recent trip to investigate the previously reported drill results on its Hillside gold project in Pilbara, Western Australia. The company is currently finalizing the grant of its tenements and preparing to undertake further mapping and sampling.
Featured Image: Depositphotos/© pressmaster
